SS&C Intralinks Success Stories

We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.

Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.

US$675 million

Teva Pharmaceutical Industries
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for US$675 million.

US$1.1 billion

Teva Pharmaceutical Industries
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for US$1.1 billion.
Stada

€5.7 billion

STADA Arzneimittel
STADA Arzneimittel,
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.

US$1.1 billion

NeuroDerm
NeuroDerm,
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for US$1.1 billion.